Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Ren Fail ; 43(1): 577-584, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33757399

RESUMEN

BACKGROUND: Uremic encephalopathy is defined as cerebral dysfunction due to toxin accumulation in patients with chronic kidney disease (CKD). This condition is characterized by subtle to florid symptoms, and its clinical course is always progressive when untreated but partially reversible with renal replacement therapy. While no test exists to measure subclinical uremic encephalopathy, two tests have been validated to measure minimal hepatic encephalopathy: the critical flicker frequency (CFF) test and the psychometric hepatic encephalopathy score (PHES). OBJECTIVE: To use CFF and PHES to measure the prevalence of cerebral dysfunction in individuals with CKD. METHODS: This cross-sectional study included a total of 69 patients with stage-5 CKD. Cutoff points for minimal encephalopathy were established using existing clinical guidelines: ≤39 Hz for CFF and < -4 for PHES. All participants were also screened for cognitive function and depression. RESULTS: Eighteen cases (26.1%) of cerebral dysfunction linked to uremic encephalopathy were detected with CFF, while twelve (17.4%) were detected by PHES; only six cases (8.7%) were diagnosed by both methods. Half of the cases (50%) had diabetes, and 61% were on hemodialysis. Cognitive function scores did not differ significantly between those receiving dialysis, hemodialysis, or no renal replacement therapy. CONCLUSIONS: It is essential to identify cerebral dysfunction when uremic encephalopathy is in early subclinical stages to reduce preventable events as traffic and work accidents.


Asunto(s)
Fusión de Flicker , Encefalopatía Hepática/diagnóstico , Pruebas Neuropsicológicas , Psicometría , Insuficiencia Renal Crónica/complicaciones , Adolescente , Adulto , Estudios Transversales , Femenino , Encefalopatía Hepática/etiología , Encefalopatía Hepática/fisiopatología , Encefalopatía Hepática/psicología , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Prevalencia , Índice de Severidad de la Enfermedad , Adulto Joven
2.
J Am Coll Nutr ; 38(3): 247-258, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30257134

RESUMEN

OBJECTIVE: Hyperphosphatemia is a major contributor to poor outcomes among cases of chronic kidney disease. Considering that foods with high protein content are major sources of phosphorus, a more suitable dietary phosphorus measure is the phosphorus to protein ratio. However, Mexican phosphorus to protein ratio tables do not exist. This article aims to estimate the phosphorus to protein ratio in foods commonly used by the Mexican population and to establish its usefulness in the selection of foods for patients with chronic kidney disease. METHODS: Six tables with the phosphorus to protein ratio were developed from different data sources concerning Mexican animal food composition. RESULTS: Egg whites have the best phosphorus to protein ratio. Partially skimmed milk has the lowest ratio among dairy products. Dairy products have high phosphorus to protein ratio variability. Red meat products have a ratio with an average of 9 mg/g. The phosphorus to protein ratio varies considerably for seafood (1.2-38.3 mg/g). CONCLUSIONS: The phosphorus to protein ratio could be a good strategy to choose each food during chronic kidney disease dietary treatment for the Mexican population.


Asunto(s)
Proteínas en la Dieta/administración & dosificación , Fósforo Dietético/administración & dosificación , Insuficiencia Renal Crónica/dietoterapia , Animales , Bovinos , Pollos , Productos Lácteos , Huevos , Humanos , Carne , México/epidemiología , Valor Nutritivo , Insuficiencia Renal Crónica/epidemiología , Alimentos Marinos , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA